Treatment of cryptosporidium infections

Details Treatment of cryptosporidium infections Treatment of cryptosporidium infections

1996-11-12

1998-09-01

Witz, Jean C.

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Bacteria or actinomycetales

C12N 120

Patent

active

058008136

ABSTRACT:
A method of reducing symptoms associated with cryptosporidia infection in mammals including humans in which L. reuteri cells are administered to the mammal in an amount sufficient to reduce diarrhea in the animal to a normal level. Daily administration as soon as cryptosporidia infection symptom are observed optimizes results. The L. reuteri cells may also be administered prophylactically to a mammal before exposure to cryptosporidia. The cells may be administered suspended in a liquid or in dry form.

REFERENCES:
patent: 5439678 (1995-08-01), Dobrogosz et al.
Argenzio, The Pig as a Model for Studying the Pathobiology of Intestinal Transport . . . , Adv. Swind Biomed Res, Plenum, NY 1966.
Gomez et al., High Levels of Inorganic Sulfate Cause Diarrhea in Neonatal Piglets, J. Nutr. 125: 2325-2332, 1995.
Alak et al., FASEB Journal 10 (3): A796 (1996).
Alak et al., Gastroenterology 110 (4 Suppl.): A852 (1996).

Affiliated with

Also associated with

Rating

Treatment of cryptosporidium infections does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of cryptosporidium infections, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cryptosporidium infections will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-267273